Corrao G - Search Results

1

The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

Trifirò G, Gini R, Barone-Adesi F, Beghi E, Cantarutti A, Capuano A, Carnovale C, Clavenna A, Dellagiovanna M, Ferrajolo C, Franchi M, Ingrasciotta Y, Kirchmayer U, Lapi F, Leone R, Leoni O, Lucenteforte E, Moretti U, Mugelli A, Naldi L, Poluzzi E, Rafaniello C, Rea F, Sultana J, Tettamanti M, Traversa G, Vannacci A, Mantovani L, Corrao G. Trifirò G, et al. Among authors: corrao g. Drug Saf. 2019 Mar;42(3):347-363. doi: 10.1007/s40264-018-0732-5. Drug Saf. 2019. PMID: 30269245 Free article. Review.

2

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.

Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, Cesana G, Mancia G. Corrao G, et al. J Hypertens. 2008 Apr;26(4):819-24. doi: 10.1097/HJH.0b013e3282f4edd7. J Hypertens. 2008. PMID: 18327094

3

Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

Zambon A, Polo Friz H, Contiero P, Corrao G. Zambon A, et al. Among authors: corrao g. Drug Saf. 2009;32(2):159-67. doi: 10.2165/00002018-200932020-00008. Drug Saf. 2009. PMID: 19236122

4

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium. Coloma PM, et al. Among authors: corrao g. Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11. doi: 10.1002/pds.2053. Epub 2010 Nov 8. Pharmacoepidemiol Drug Saf. 2011. PMID: 21182150

5

Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium. Coloma PM, et al. Among authors: corrao g. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):611-21. doi: 10.1002/pds.3197. Epub 2012 Feb 8. Pharmacoepidemiol Drug Saf. 2012. PMID: 22315152

6

Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database.

Lapi F, Nicotra F, Scotti L, Vannacci A, Thompson M, Pieri F, Mugelli N, Zambon A, Corrao G, Mugelli A, Rubino A. Lapi F, et al. Among authors: corrao g. Br J Clin Pharmacol. 2012 Sep;74(3):536-44. doi: 10.1111/j.1365-2125.2012.04224.x. Br J Clin Pharmacol. 2012. PMID: 22356433 Free PMC article.

7

Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study.

Bonifazi M, Franchi M, Rossi M, Moja L, Zambelli A, Zambon A, Corrao G, La Vecchia C, Zocchetti C, Negri E. Bonifazi M, et al. Among authors: corrao g. Oncologist. 2013;18(7):795-801. doi: 10.1634/theoncologist.2013-0065. Epub 2013 Jul 3. Oncologist. 2013. PMID: 23823908 Free PMC article.

8

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures.

Corrao G, Ghirardi A, Segafredo G, Zambon A, Della Vedova G, Lapi F, Cipriani F, Caputi A, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Di Bari M; BEST investigators. Corrao G, et al. Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):859-67. doi: 10.1002/pds.3650. Epub 2014 Jun 9. Pharmacoepidemiol Drug Saf. 2014. PMID: 24911392

9

Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: a large cohort study from clinical practice.

Bonifazi M, Franchi M, Rossi M, Zambelli A, Moja L, Zambon A, Corrao G, La Vecchia C, Zocchetti C, Negri E. Bonifazi M, et al. Among authors: corrao g. Breast. 2014 Oct;23(5):573-8. doi: 10.1016/j.breast.2014.05.022. Epub 2014 Jun 13. Breast. 2014. PMID: 24934637 Free article.

10

Effectiveness of trastuzumab in first-line HER2+ metastatic breast cancer after failure in adjuvant setting: a controlled cohort study.

Negri E, Zambelli A, Franchi M, Rossi M, Bonifazi M, Corrao G, Moja L, Zocchetti C, La Vecchia C. Negri E, et al. Among authors: corrao g. Oncologist. 2014 Dec;19(12):1209-15. doi: 10.1634/theoncologist.2014-0227. Epub 2014 Oct 29. Oncologist. 2014. PMID: 25355843 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page